Moreover, nesfatin-1 had excellent sensitivity (97.9%) at diagnosing NPC, which would make up the shortfall of EA-IgA, VCA-IgA and Rta-IgG for their low sensitivity in NPC diagnosis. Here, NUCB2 is linked to nasopharyngeal carcinoma.